Senior Management

Our management team consists of both industrial and academic scientists with decades of cumulative experience working on insoluble or poorly bioavailable compounds. This translates into an expert understanding of the real requirements of preclinical and clinical development, as well as cGMP and the importance of regulatory acceptability of excipients and manufacturing processes.

Key Staff

Professor Graham Buckton - CEO & Founder

Dr Chris Kirby - Senior Director of Research

Dr Mark Hooper - Director of Project Management 

Chris Landeg - Director of Business Development

Bruce Lithgow - Director of Product Development

Mridul Majumder -  Director of Physical Properties

Paul Went - Director of Quality

Dr Bildad Nyambura - Head of Respiratory Drug Delivery